ABC | Volume 113, Nº4, October 2019

Updated Updated Cardiovascular Prevention Guideline of the Brazilian Society Of Cardiology – 2019 Arq Bras Cardiol. 2019; 113(4):787-891 immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2018;104(2):119-26. 512. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26(Suppl 51):S35-61. 513. Jagpal, A, Navarro-Millán, I. Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment. BMC Rheumatol. 2018 Apr;2:10. 514. Bryant RE, Geoffrey MT, Daniel RA, Ted RM. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018 Apr;361:k1036. 515. Kazelian L. Autoimune Diseases Promoting Coronary Artery Disease in Women. Rev Argent Cardiol. 2013;81(4):330-4. 516. Liu Y, KaplanM. Cardiovascular disease in systemic lupus erythematosus. Curr Opin Rheumatol. 2018;30(5):441–8. 517. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS ONE. 2016;11(7):e0158765. 518. Marinho AW, Penha AP, SilvaMT, Galvão TF. Prevalência de doença renal crônica em adultos no Brasil: revisão sistemática da literatura. Cad Saúde Colet. 2017;25(3):379-88. 519. Foley RN,Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc. 2005;80(10):1270-7. 520. Subbiah AK, Chhabra YK, Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia. 2016;8(2):56–61. 521. Mark PB. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrol Dial Transplant. 2018;33(1):23-5. 522. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. 523. Schiffrin EL, Lipman ML, Mann JF. Chronic Kidney Disease Effects on the Cardiovascular System. Circulation. 2007;116(1):85-97. 524. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341-52. 525. Greffin S, Andre MB, Matos JP, Kang HC, Jorge AJ, Rosa ML, et al. Doenca renal cronica e sindrome metabolica como fatores de risco para doenca cardiovascular em um programa de atenço primaria. J Bras Nefrol. 2017;39(3):246-52. 526. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease - A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050-65. 527. Palmer SC, Di Micco L, RazavianM, Craig JC, Perkovic V, Pellegrini F, et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013 Feb;2:CD008834. 528. Drager LF, Lorenzi-Filho G, Cintra FD, Pedrosa RP, Bittencourt LR, Poyares D, et al, Sociedade Brasileira de Cardiologia. 1º Posicionamento Brasileiro sobre o impacto dos disturbios de sono nas doencas cardiovasculares da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2018;111(2):290-341. 529. Floras JS. Sleep apnea and cardiovascular disease an enigmatic risk factor. Circ Res. 2018;122(12):1741-64. 530. Drager LF, McEvoyD, Barbe F, Lorenzi-FilhoG, Redline S. SleepApnea and Cardiovascular Disease - Lessons From Recent Trials and Need for Team Science. Circulation. 2017;136(19):1840–50. 531. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–53. 532. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034–41. 533. Loke YK, Brown JW, Kwok CS, Niruban A, Myint PK. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5(5):720–8. 534. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–14. 535. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417–23. 536. Campos-Rodriguez F, Martinez-GarciaMA, de la Cruz-Moron I, Almeida- Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med. 2012;156(2):115-22. 537. Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V, et al. Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea - A Systematic Review and Meta- analysis. JAMA. 2017;318(2):156-66. 538. SarrisAB,NakamuraMK,FernandesLG,StaichakRL,PupulimAF,Sobreiro BP. Fisiopatologia, avaliação e tratamento da disfunção erétil: artigo de revisão. Rev Med (São Paulo). 2016;95(1):18-29. 539. Abdo CH. Perfil sexual da população brasileira: resultado do estudo do comportamento sexual (ECOS) do brasileiro. Rev Bras Med. 2002;59(4):250-7. 540. Abdo CHN, ScanavinoMT, Martins FG, Oliveira Jr WM. Disfunção erétil: resultados do estudo da vida sexual do brasileiro. Rev Assoc Med Bras. 2006;52(6):424-9. 541. Abdo CH, Afif-Abdo J. Estudo populacional do envelhecimento (EPE): primeiros resultados masculinos. Rev Bras Med. 2007;64(8):379-83. 542. TeixeiraAS,PereiraBJ.Disfunçãoerétilcomomarcadorprecocededoença cardiovascular. Rev Factores Risco. 2012;(25):8-11. 543. Grimm Jr RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension. 1997;29(1):8-14. 544. Parazzini F, Menchini FF, Bortolotti A, Calabrò A, Chatenoud L, Colli E, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;37(1):43-9. 545. Jackson G. Erectile dysfunction and cardiovascular disease. Arab J Urol. 2013;11(3): 212–6. 546. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58(13):1378-85. 547. Banks E, Joshy G, Abhayaratna WP, Kritharides L, Macdonald PS, Korda RJ, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalization and all-causemortality: a prospective cohort study. PLoS Med. 2013;10(1):e1001372. 883